Press "Enter" to skip to content

New tentative approval for Dr Reddys drug ticagrelor

1
Copyright © DrugPatentWatch. Originally published at New tentative approval for Dr Reddys drug ticagrelor [![ticagrelor structure](https://www.DrugPatentWatch.com/img/drug-structure/ticagrelor.png)](//www.DrugPatentWatch.com/p/preview/generic-api/ticagrelor?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog)
Ticagrelor is the generic ingredient in two branded drugs marketed by Astrazeneca Pharms, Amneal, Hisun Pharm Hangzhou, Sigmapharm Labs Llc, Sunshine, and Watson Labs Inc and, and is included in six NDAs. There are four patents protecting this compound.

Drug patent litigation for TICAGRELOR.

This ingredient has two hundred and one patent family members in forty-eight countries.

Three suppliers are listed for this compound. There are five tentative approvals for this compound.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New tentative approval for Dr Reddys drug ticagrelor
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!